Travere Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Patent Application No. 19/253,088, titled "Biphenyl ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results